Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

Scandinavian ChemoTech

2.04

 

SEK

 

-0.49 %

Less than 1K followers

CMOTEC B

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Ownership
Investor consensus
Compare
-0.49%
+37.84%
+65.85%
+13.97%
+16.57%
-11.17%
-81.47%
-81.7%
-94.58%

Scandinavian ChemoTech is a research and development company that has developed the technology Tumor-Specific Electroporation - TSE ™ for the treatment of various cancers. The technology means that electronic pulses are sent to the treated area and the membranes of the tumor cells are opened to reach their DNA. In addition to its operations in Sweden, the company is also active in Southeast Asia and India. Scandinavian ChemoTech was founded in 2015 and is headquartered in Lund.

Read more
Market cap
47.62M SEK
Turnover
4.52K SEK
Revenue
6.57M
EBIT %
-194.82 %
P/E
-
Dividend yield-%
-
Financial calendar
12/8
2025

Interim report Q2'25

4/11
2025

Interim report Q3'25

3/3
2026

Annual report '25

All
Press releases
3rd party
ShowingAll content types
Regulatory press release5/13/2025, 1:15 PM

Kommuniké från årsstämma i Scandinavian ChemoTech AB (publ) den 13 maj 2025

Scandinavian ChemoTech
Press release5/7/2025, 10:11 AM

Redeye: Scandinavian ChemoTech - Momentum continues

Scandinavian ChemoTech
Regulatory press release5/6/2025, 6:30 AM

Scandinavian ChemoTech AB (publ) publishes Interim Report Q1 2025

Scandinavian ChemoTech

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Press release5/2/2025, 6:30 AM

(RETRANS) ChemoTech's Animal Care Celebrates Record-Breaking Month with Order Intake of 200,000 USD

Scandinavian ChemoTech
Regulatory press release5/1/2025, 4:15 AM

ChemoTech's Animal Care Celebrates Record-Breaking Month with Order Intake of 200,000 USD in April

Scandinavian ChemoTech
Regulatory press release4/25/2025, 7:15 AM

ChemoTech: Animal Care expands U.S. presence with new partnership, securing an order of appr. USD 66,000

Scandinavian ChemoTech
Regulatory press release4/22/2025, 6:28 PM

Rättelse: Scandinavian ChemoTech publicerar 2024 års årsredovisning

Scandinavian ChemoTech
Regulatory press release4/22/2025, 9:00 AM

Scandinavian ChemoTech publicerar 2024 års årsredovisning

Scandinavian ChemoTech
Regulatory press release4/10/2025, 4:45 PM

Kallelse till årsstämma i Scandinavian ChemoTech AB

Scandinavian ChemoTech
Regulatory press release4/1/2025, 7:15 AM

Scandinavian ChemoTech Starts 2025 Strong with Q1 Order Intake Exceeding USD 230,000

Scandinavian ChemoTech
Regulatory press release3/21/2025, 11:53 AM

Scandinavian ChemoTech Secures New Order and Expands Animal Care Operations Through Global Collaboration in Equine Oncology

Scandinavian ChemoTech
Press release3/4/2025, 5:45 PM

Redeye: Scandinavian ChemoTech - Continued growth in recurring revenues

Scandinavian ChemoTech
Regulatory press release3/4/2025, 7:30 AM

Scandinavian ChemoTech AB (publ) publishes Year-End Report January - December 2024

Scandinavian ChemoTech
Regulatory press release1/30/2025, 8:31 AM

Scandinavian ChemoTech Restructures Loans and Doubles the Duration to 12 Months

Scandinavian ChemoTech
Regulatory press release1/24/2025, 7:50 AM

ChemoTech: Scandinavian ChemTech's Animal Care operations showed positive cashflow for 2024 in separate reporting

Scandinavian ChemoTech
Press release1/24/2025, 7:30 AM

ChemoTech: Latest News: New Website for TSE - A Potential New Paradigm in Cancer Care

Scandinavian ChemoTech
Regulatory press release1/9/2025, 9:00 AM

Scandinavian ChemoTech Implements Management Changes to Reduce Costs and Boost Revenues

Scandinavian ChemoTech
Press release1/9/2025, 7:30 AM

ChemoTech byter språk för offentliggörande av information

Scandinavian ChemoTech
Press release1/9/2025, 7:30 AM

ChemoTech changes language for information disclosure

Scandinavian ChemoTech
Regulatory press release12/30/2024, 1:10 PM

Scandinavian ChemoTech delar upp affärsområdena för att stärka kassaflödet och kommer att föreslå ett nytt namn för koncernen

Scandinavian ChemoTech
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team